Document is current
Any future updates will be listed below
-
Authors
Pettit, Amy R. https://orcid.org/0009-0008-0115-8412
Klaiman, Tamar https://orcid.org/0000-0001-8718-5674
Kersting, Rebecca Connelly
Johnson, Christina https://orcid.org/0009-0009-1747-2999
Ogbuefi, Nkiru
Moran, Maeve https://orcid.org/0000-0002-9675-5488
Sinclair, Krystin
Steckel, Jenna
Norton, Laurie
Orr, Jennifer A. https://orcid.org/0000-0001-7612-2432
Lieberman, Adina https://orcid.org/0009-0002-2498-561X
McGowan, Mary P. https://orcid.org/0000-0001-5761-9267
Tricou, Eric https://orcid.org/0000-0002-8098-1990
Chen, Jinbo https://orcid.org/0000-0003-3174-2552
Rader, Daniel J. https://orcid.org/0000-0002-9245-9876
Volpp, Kevin G. https://orcid.org/0000-0003-3389-6707
Beidas, Rinad S. https://orcid.org/0000-0001-6056-6071
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-21-1-0421)
U.S. Department of Defense (W81XWH-21-1-0420)
- License Information
-
More Information
Article History
Received: 25 April 2024
Accepted: 18 November 2024
First Online: 2 December 2024
Declarations
:
: This study was approved by the University of Pennsylvania Institutional Review Board (Protocol #849516). Informed consent was obtained from all participants.
: Not applicable.
: At the time of the study, MPM was Chief Medical Officer at the nonprofit Family Heart Foundation. ET is a genetic counselor and care navigator at the Family Heart Foundation. DJR is the Chief Scientific Advisor and immediate past Chair of the Board at the Family Heart Foundation and is on the Scientific Advisory Board of Alnylam Pharmaceuticals, Novartis, and Verve Therapeutics. He is a founder of VascularStrategies LLC and a consultant for Regeneron Pharmaceuticals, Inc. KGV is a part-owner of VALHealth, a behavioral economics consulting firm, and receives research funding from Independence Blue Cross and research funding and consulting support from the American Heart Association, none of which are related to the work described in this manuscript. He is also a Scientific Advisory Board member of Thrive Global and receives equity stock options for his role (also unrelated to this manuscript). RSB is the principal at Implementation Science & Practice, LLC. She receives royalties from Oxford University Press and consulting fees from United Behavioral Health and OptumLabs. She is currently an appointed member of the National Advisory Mental Health Council and the NASEM study, “Blueprint for a National Prevention Infrastructure for Behavioral Health Disorders,” and serves on the advisory boards for AIM Youth Mental Health Foundation and the Klingenstein Third Generation Foundation, outside of the submitted work. The remaining authors (ARP, TK, RCK, CJ, NO, MM, KS, JS, LN, JAO, AL, and JC) declare that they have no competing interests.
